1000000 Participants NeededMy employer runs this trial

Preventive Health Screening for Preventive Health Services

(HACE Trial)

WB
Overseen ByWilliam Brandenburg, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: William Brandenburg, MD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial focuses on testing new methods to enhance preventive health screenings. Researchers compare AI-assisted interpretation of screening data with the traditional human-only approach to determine which is more effective. They also plan to test various methods of delivering health reports and screenings, including Hybrid Medical Droid and Human Delivered Health Screenings, Interactive Personalized Health Reports, and Mobile Community-Based Health Screenings. Individuals who can provide consent and are open to long-term follow-up may be suitable candidates for this trial. As an unphased trial, this study offers participants the chance to contribute to innovative approaches in preventive health care.

What prior data suggests that these preventive health screening methods are safe?

Research shows that digital healthcare tools, such as those using AI and mixed systems, can enhance preventive care. These tools help detect diseases like cancer and diabetes early, and people generally respond well to them. For instance, healthcare chatbots have reduced hospital readmissions by up to 25%, demonstrating their effectiveness with minimal side effects.

Mobile health clinics also excel at providing screening services. Studies indicate these clinics deliver preventive care effectively, especially in areas with limited healthcare access, proving their safety and usefulness for many people.

Interactive health reports provide personalized and practical health information. Research has shown that these reports improve health management, confirming their safety and ease of use.

Overall, research suggests these technologies are generally safe and well-received.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores innovative ways to improve preventive health screenings. The trial compares traditional human-only interpretation of screening data with a cutting-edge AI-assisted approach. The AI-assisted method uses advanced models to generate preliminary reads of medical data, which are then reviewed by physicians. This could potentially enhance accuracy and efficiency in diagnostics. Additionally, the trial includes mobile community-based screenings, which aim to make health services more accessible to underserved populations. By integrating technology with traditional methods, this trial seeks to uncover whether AI and mobile health services can lead to better health outcomes and greater accessibility.

What evidence suggests that this trial's treatments could be effective?

Research has shown that using AI in health screenings can improve the accuracy of interpreting health data. In this trial, participants will join different arms to evaluate the effectiveness of AI-assisted screening interpretation compared to human-only interpretation. Studies have found that AI, when used alongside human review, makes the screening process more efficient and precise. In tests, AI-assisted systems identified health issues more quickly and reliably than methods relying solely on humans.

For the hybrid medical droid delivery model, studies indicate that combining technology with human oversight increases people's involvement in their health and use of preventive services. Research on mobile community health screenings shows they are cost-effective and improve access to preventive services, especially in areas with limited resources. These methods are linked to better health outcomes and more effective screenings.678910

Who Is on the Research Team?

WB

William Brandenburg, MD

Principal Investigator

Longevity Metrics

Are You a Good Fit for This Trial?

This trial is for adults interested in preventive health, especially those at risk for heart disease, metabolic issues, cognitive decline, or frailty. It aims to include people from all backgrounds and locations, including rural and underserved communities.

Inclusion Criteria

Willing and able to provide written informed consent, or enrollment with consent of a legally authorized representative
I am willing to participate in long-term follow-up visits.
I am 18 years old or older.

Exclusion Criteria

I am under 18 years old.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Active Comparison

AI-assisted versus human-only interpretation of screening data. Participants undergo comprehensive preventive health screening with data interpreted by either AI or human-only methods.

6-12 months
Multiple visits as per comparison protocol

Follow-up

Participants are monitored for safety and effectiveness after treatment, with follow-up assessments including health awareness and action scores.

6-12 months, then periodically up to 100 years
Periodic follow-up visits

Planned Comparisons

Subsequent comparisons include static versus interactive report delivery, mobile versus fixed screening, and hybrid delivery models.

Ongoing

What Are the Treatments Tested in This Trial?

Interventions

  • Hybrid Medical Droid and Human Delivered Health Screenings
  • Interactive Personalized Health Report
  • Mobile Community-Based Health Screenings

Trial Overview

The study compares different ways of delivering health screenings: interactive personalized reports vs. standard ones; mobile community-based screenings vs. fixed labs; and a mix of medical droid plus human screening vs. human-only methods.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: AI-Assisted Screening Interpretation (AI Reads)Experimental Treatment1 Intervention
Group II: Human-Only Screening InterpretationActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

William Brandenburg, MD

Lead Sponsor

Citations

Health Ahead Comparative Effectiveness Study

Comparison 3: A hybrid delivery model combining medical droids, one registered nurse, and remote physician oversight, versus human-only screening. Future: Fully ...

Preventive Service Usage and New Chronic Disease ...

This study of over 30 million US adults during 2018 through 2022 leveraged electronic health record (EHR) data from PCORnet, a national network, ...

Digital Health Interventions to Enhance Prevention in Primary ...

DHI users were providers (205/241, 85.1%), patients (111/241, 46.1%), or multiple types (89/241, 36.9%). Reported outcomes were primarily clinical (179/241, ...

Health Ahead Comparative Effectiveness Study - OpenTrials

Hybrid Medical Droid and Human Delivered versus Human-Only Delivered Health Screenings. Primary outcomes. Health Activation and Engagement ...

A type 1 hybrid design randomized trial to decrease HIV ...

To address this gap, the Positive Health Check Evaluation Trial uses a type 1 hybrid randomized trial design to test whether the use of a highly tailored video ...

The promise of digital healthcare technologies - PMC - NIH

Patients can have access to their health information, including medical records, test results, and self-management tools, via digital health ...

Digital health: current applications, challenges, and future ...

DHTs have demonstrated transformative potential across healthcare, spanning disease prevention, diagnosis, treatment, and prognosis, thereby ...

Recent Advances in AI-Driven Mobile Health Enhancing ...

In preventive care, AI-enabled mobile tools improve oral health screening [25], early oral cancer detection [23], diabetic retinopathy [43], and sleep apnea ...

The Application of Preventive Medicine in the Future Digital ...

These data can help predict disease progression and enable a shift toward preventive health care, empowering patients to actively manage their ...

the transformative role of AI-powered hybrid chatbots in ...

Results Hybrid chatbots in healthcare have shown significant benefits, such as reducing hospital readmissions by up to 25%, improving patient ...